MarketsStocksERIS
ER

Eris Lifesciences Ltd

NSE: ERISBSE: 540596Healthcare
Download Research Report7-page PDF
1,371.70
+0.48%
NSE · auto-updates while market open
Prev Close
₹1,638.30
Day High
₹1,385.00
Day Low
₹1,348.00
Mkt Cap
₹18,915 Cr
P / E
29.2
P / B
4.8
ROE
19.2%
52W High
₹1,910.00
52W Low
₹1,200.00
Key Metrics
Market Cap
₹18,915 Cr
P / E
29.21
P / B
4.84
EV / EBITDA
19.18
ROCE
14.4%
ROE
19.2%
Debt / Equity
0.59
Book Value
₹281.78
EPS
₹45.33
Div Yield
0.5%
Face Value
₹1
Promoter Holding
53.9%
Revenue · ₹ Cr
1.1k
FY20
1.2k
FY21
1.3k
FY22
1.7k
FY23
2.0k
FY24
2.9k
FY25
3.1k
FY26
Net Profit · ₹ Cr
297
FY20
355
FY21
406
FY22
374
FY23
397
FY24
375
FY25
648
FY26
EPS · ₹ per share
₹21.6
FY20
₹26.2
FY21
₹29.9
FY22
₹28.1
FY23
₹28.8
FY24
₹25.9
FY25
₹45.3
FY26
P / E Ratio · price ÷ TTM EPS
1435567752240-4Jun 21Feb 23Oct 24Jun 26
P/E 30.1×Median 29.9×TTM EPS
Q1 2026 snapshot
Sales
₹759 Cr
Operating profit
-
OPM
-
Net profit
₹279 Cr
EPS
₹20.60
Scorecard · 7 axes
Quality
Good
63/100
Valuation
Avg
29.2×
Growth
Good
+17.9%
Profitability
Good
16.8%
Performance
Bad
-17.4%
Entry Point
Good
72%
Red Flags
Strong
0 flags
Shareholding Pattern
53.9%Promoter
Promoter53.9%
FII6.4%
DII20.4%
Public19.3%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue727.45713.25775.69795.22807.47758.79
Net Profit86.93102.35125.1134.47108.83279.1
NPM %11.9%14.3%16.1%16.9%13.5%36.8%
AlertPre-trade